Tesamorelin / Ipamorelin

Tesamorelin with Ipamorelin. The stronger GH blend, weighted toward visceral fat reduction.

Swaps the gentle GHRH for Tesamorelin — the stabilised analog that's FDA-approved (as Egrifta) for visceral fat reduction in HIV lipodystrophy, and the reason this blend is chosen over CJC/Ipa when body composition is the goal rather than recovery. Stronger means more side-effect surface: water retention and joint aches are the usual complaints.

Dose

Dosed as a single draw — the ratio is fixed by the vial (5 / 5 mg), so you scale all 2 components together. Use the dose calculator to convert your target to units. Vials also come as 5 / 5 mg, 10 / 5 mg, 10 / 10 mg.

Reconstitute

5 / 5 mg vial + 2 mL bacteriostatic water. 10 units on a U-100 syringe = 250 mcg Tesamorelin + 250 mcg Ipamorelin. Other dilutions the calculator supports: 2, 3 mL.

Schedule

5 nights on / 2 off, 12+ week cycles.

Half-life

Tesamorelin ~30 minutes injected; Ipamorelin ~2 hours. Downstream IGF-1 elevation lasts considerably longer.

Timing

Pre-bed fasted, or AM fasted. Keep ≥2 hours clear of food.

Risks

Water retention, joint aches, carpal-tunnel symptoms, and glucose intolerance at higher doses. Monitor IGF-1 and fasting glucose if running this long.

Educational reference — not medical advice. Many peptides are not approved for the uses discussed; verify status in your jurisdiction and decide anything here with a qualified clinician.

within Blends & Combos